from treatment with mutagenic agents Thus, the equations describing incidence as a function of exposure to cardnogenic agents include two separate terms, one accounting for mutagenic and one for mitogenic stimuli. At high exposures these interact, producing synergism and high incidence rates, but at low exposures they are effectively independent. The multis modelsthat are now used include only terms corresponding to the mutanstimuli and thus fail to adequately describe incidence at high dose rates Biologically based models attempt to include mitogenic effects, as well; they are usualy nUited by data availability.
Introduction
Amid the controversy that has swirled around procedures for extrapolating cancer hazard functions to very small exposures, there has been a frequent assertion that the procedures have no scientific foundation. Implied in that assertion is the idea that procedures lacking such a foundation cannot serve a useful function in public health. This paper explores the foundations of dose-response models.
A variety ofmathematical models have been used (or proposed to be used) over the last 15 years to draw inferences about the hazard function for cancer in exposures far below where a doseresponse can be observed. They can be divided into two groups: those based on some tolerance distribution (probit, logit, Weibull) and those that derive, one way or another, from models for the age-specific incidence ofcancer. Included among the latter are the gamnua-multihit procedure, the linearized (LMS) procedure of Guess et al. (1) , and the several recent procedures sometimes called biologically based models (2) (3) (4) .
"Biologically based models" carries a connotation that the widely used probit, Weibull, and LMS procedures are not based on the biology we know. That clearly is not so. What is true is that the more recent procedures are derived from a more nearly complete theory-Moolgavkar and Knudson's two-event theory of carcinogenesis (5) 
Tolerance-Distribution Models
It is now generally accepted that the probit and Weibull models and related procedures are phenomenologically based. They successfully describe a broad range of phenomena relevant to the estimation of a carcinogen hazard function. Probit and related mathematical models describe the dose-response curves usually observed in the medical sciences, whereas Weibull-type functions describe mortality. Yet, it is also recognized that there are not underlying theoretical bases for these particular functions. Further, the data used to derive these models are not precise enough to permit good tests oftheir reliability, even at incidences in the 1% range (W. J. Adams et al., unpublished results). Thus, no statement can be made about how well each might represent reality when extrapolated to incidences well below the observable range (i.e., risks of 10-3 or smaller). Because the incidence predicted by the probit function declines more rapidly with decreasing dose than that ofany other commonly used function, it might be considered to represent a conceptual (not statistical) lower bound to the extrapolated function. Such use is arbitrary.
Model-Free Procedures
Gaylor et al. (6) (2, 3, 12, 16) . This theory recognizes that certain treatments may increase the net birth rates of initiated cells. These lead to expansion of the clone of initiated cells; again borrowing from experimental cancer, the process is termed "promotion" (5, 15) . Because it is recognized that adventitious (background or spontanes) initiation occurs through the natural mutagenic flux, the theory predicts that pure promoters (agents with little or no mutagenic activity) will act as complete carcinogens in ordinary bioassays. This suggests that the term "complete carcinogen" conveys nothing and that its use should be discontinued.
The theory of carcinogenesis rationalizes a large number of observations from experimental science, epidemiology, and clinical practice (2) (3) (4) (5) 15) . In addition, a number of predictions made from the theory have been verified, particularly the phenomenon called I-P-I (initiation-promotion-initiation) (13) . The theory provides a good explanation for the age-specific incidences of essentially all cancers (5, 11) , including the adult cancer for which the Armitage-Doll model provided an earlier, different explanation. The Armitage-Doll explanation is now regarded as inadequate (20) . Like Armitage-Doll, the current theory is a member of the set of multi-event models, although more specific than earlier ones in that it gives specific identification to the several events. The theory differs from earlier theories in the explicit place provided for effect ofincreased mitotic rate on cancer risk. Both the various linear extrapolation procedures and the more recent biologically based models can be derived from this theory.
Extrapolation Procedures: Linear Models
It is convenient to discuss derivation ofthe various procedures, their applicability, and their limitations in the context of Moolgavkar's approxinate solution to the age-specific incidence (5, 16) .
Here X(s) denotes the number of normal stem cells at time s, it, and I2 are the mutation rates ofnorma and initiat cels, and (a2 -(32) is the net birth rate of initiated cells. [As Moolgavkar and Dewanji pointed out (17) , this equation is valid only for I(t) < 0.2; at higher incidence a more nearly exact formulation must be used.] In this formulation, the synergistic effects of initiated cell mitotic rate on mutation probability become apparent.
Eq. (1) assumes only adventitious initiation and no effect of treatment on any ofthe other parameters. Generalizing, taking L = p + 1t,(d), where y0 is the adventitious rate, we obtain: (2) In other words, treatment is allowed to affect any or all of the several parameters in the model.
Ifexperimental conditions are such that we can assume the integral term to be constant over a series ofexperiments carried to constant time t, then Eq. (3) results. 
Limitations of Linear Models
Two serious constraints exist for the linear models. The approximation from which they can be derived is valid only for relatively low values of I, and there must be no significant increase in the mitotic rate of either normal or initiated cells. In fact, it appears from the recent work ofCohen and Ellwein (2, 3) that the first condition will usually be met if the second one is met. Their work suggests that treatment conditions that increase mitotic rate cause the incidence versus exposure curve to bend sharply upward. At present, we know only one example ofan experiment yielding a tumor incidence in the 20% to 30% range where the dose response is linear, viz., the liver tumors in mice treated with 2-AAF in the EDO1 study (21) . According to Cohen and Ellwein's recent analysis (21) , no evidence for a mitotic rate increase is seen. Otherwise, so far, whenever relevant evidence is available, high incidence seems to be accompanied by mitotic rate increase (15) . (Note that only a few well-characterized examples are yet available.)
The importance ofthis mitotic rate increase is quite clear. Application oflinear models to high dose-rate data giving high incidence is not appropriate. To apply linear models under those circumstances will greatly exaggerate the estimated incidence. It is especially inappropriate to apply these procedures with data sets from treatment with nongenotoxic compounds. However, it may be appropriate to use these methods for strongly genotoxic compounds, when the data show no evidence for curvalinearity. It is also clear that we need to investigate further the behavior of mitotic rate under treatnent with mitogens so that we can begin to address the deficiencies in these linear methods.
Biologically Based Models
Thorslund et al. (4) coined the phrase "biologically based nwdels" to describe the family ofmodels they have explored. Implied by the phrase is a notion that other models are not biologically based and thus somehow inferior. This is not necessarily the the case. Thorslund's model structures, in particular, suffer from an inability to incorporate time-dependence ofcell number, mitotic rate, etc. They are thus vulnerable to being criticized as unrealistic. Moolgavkar has recendy published a series ofpapers describing increasingly less approximate solutions to the general model. The latest of these gives an exact, though very complex, solution and an application to radiationinduced cancer data (16) . In principle, these sets of equations should yield reliable estimates ofthe hazard function below the observable range, since their biological base is the best known. In practice, the successfl use ofthese equations for this purpose will be some time in the future because their solution requires data not gnerally aailable, and the effects ofvarious approximations and default parameters have not yet been adequately explored. Nevertheless, this development is one of the most exciting in risk assessment in recent years. 
